USPTO serial 79417341
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew S. Ehard
, P.O. Box 2910Minneapolis, MN 55402United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Isotopes for medical purposes; Radio-isotope markers for therapeutic or diagnostic use; Chemical products for pharmaceutical use being pharmaceutical products for the diagnosis and treatment of cancer; Pharmaceutical drugs being pharmaceutical products for the diagnosis and treatment of cancer, or skeletal, renal, cardiovascular or neurological disorders; Pharmaceutical preparations for diagnosing and suppressing tumors; Pharmaceutical preparations for the treatment of cancer; Diagnostic radiopharmaceutical preparations | ACTIVE | — |
| 010 | Diagnostic imaging apparatus for medical use; Medical apparatus for detecting cancer, or skeletal, renal, cardiovascular or neurological disorders; Systems comprising medical apparatus and accessories for administering measured doses of pharmaceutical preparations, namely, infusion and injection devices for administering drugs; Applicators for pharmaceutical preparations, namely, medical syringes and infusion sets | ACTIVE | — |
| 035 | Wholesale and retail store services featuring radiopharmaceuticals for clinical and medical use; Wholesale and retail store services featuring pharmaceuticals, medical preparations and veterinary preparations; Wholesale and retail store services featuring medical apparatus for detecting cancer, or skeletal, renal, cardiovascular or neurological disorders | ACTIVE | — |
| 039 | Transportation of goods; transport and storage of chemicals; storage of pharmaceuticals. | ACTIVE | — |
| 040 | Custom manufacture of pharmaceuticals; custom manufacture of pharmaceutical preparations. | ACTIVE | — |
| 042 | Calibration of medical apparatus for detecting and treating cancer or skeletal, renal, cardiovascular or neurological disorders; Calibration of laboratory test equipment; Radiation measurement services; Scientific research and development for medical purposes in the fields of cancerous diseases or skeletal, renal, cardiovascular or neurological disorders | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 10, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 3, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 24, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 24, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 6, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 30, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 20, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 19, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 3, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 3, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 3, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 22, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 13, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 13, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 7, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 1, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 13, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 8, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 8, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 8, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 11, 2025 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jun 28, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 6, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 6, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 2, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 1, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 20, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 23, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 23, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 20, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |